SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 305 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.70 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $787,445 | +1.4% | 6,496 | -4.2% | 0.00% | 0.0% |
| Q2 2023 | $776,216 | -36.6% | 6,778 | -23.6% | 0.00% | -50.0% |
| Q1 2023 | $1,223,517 | +13.0% | 8,877 | +6.3% | 0.00% | 0.0% |
| Q4 2022 | $1,082,382 | -20.6% | 8,353 | -32.4% | 0.00% | -33.3% |
| Q3 2022 | $1,364,000 | +46.8% | 12,355 | -0.3% | 0.00% | +50.0% |
| Q2 2022 | $929,000 | -0.9% | 12,395 | +3.3% | 0.00% | 0.0% |
| Q1 2022 | $937,000 | -15.4% | 12,003 | -2.5% | 0.00% | 0.0% |
| Q4 2021 | $1,107,000 | +10.9% | 12,309 | +14.1% | 0.00% | 0.0% |
| Q3 2021 | $998,000 | +25.5% | 10,790 | +5.5% | 0.00% | +100.0% |
| Q2 2021 | $795,000 | +19.9% | 10,224 | +15.2% | 0.00% | 0.0% |
| Q1 2021 | $663,000 | -25.5% | 8,874 | +70.0% | 0.00% | -50.0% |
| Q4 2020 | $890,000 | +159.5% | 5,220 | +114.0% | 0.00% | +100.0% |
| Q3 2020 | $343,000 | -8.5% | 2,439 | +4.3% | 0.00% | 0.0% |
| Q2 2020 | $375,000 | +63.0% | 2,339 | -0.5% | 0.00% | 0.0% |
| Q1 2020 | $230,000 | -22.0% | 2,351 | +3.2% | 0.00% | 0.0% |
| Q4 2019 | $295,000 | +58.6% | 2,279 | -7.4% | 0.00% | 0.0% |
| Q3 2019 | $186,000 | +2.8% | 2,462 | +106.4% | 0.00% | 0.0% |
| Q2 2019 | $181,000 | +48.4% | 1,193 | +16.1% | 0.00% | – |
| Q1 2019 | $122,000 | +18.4% | 1,028 | +9.0% | 0.00% | – |
| Q4 2018 | $103,000 | -31.8% | 943 | +1.4% | 0.00% | – |
| Q3 2018 | $151,000 | -21.8% | 930 | -36.3% | 0.00% | -100.0% |
| Q2 2018 | $193,000 | +12.2% | 1,460 | -36.9% | 0.00% | 0.0% |
| Q1 2018 | $172,000 | -26.8% | 2,315 | -45.2% | 0.00% | 0.0% |
| Q4 2017 | $235,000 | +65.5% | 4,224 | +35.0% | 0.00% | – |
| Q3 2017 | $142,000 | +61.4% | 3,129 | +19.2% | 0.00% | – |
| Q2 2017 | $88,000 | +29.4% | 2,624 | +14.2% | 0.00% | – |
| Q1 2017 | $68,000 | +88.9% | 2,298 | +72.9% | 0.00% | – |
| Q4 2016 | $36,000 | +414.3% | 1,329 | +1007.5% | 0.00% | – |
| Q3 2016 | $7,000 | +250.0% | 120 | 0.0% | 0.00% | – |
| Q2 2016 | $2,000 | 0.0% | 120 | 0.0% | 0.00% | – |
| Q1 2016 | $2,000 | -60.0% | 120 | 0.0% | 0.00% | – |
| Q4 2015 | $5,000 | +25.0% | 120 | 0.0% | 0.00% | – |
| Q3 2015 | $4,000 | 0.0% | 120 | 0.0% | 0.00% | – |
| Q2 2015 | $4,000 | +100.0% | 120 | 0.0% | 0.00% | – |
| Q1 2015 | $2,000 | 0.0% | 120 | 0.0% | 0.00% | – |
| Q4 2014 | $2,000 | -33.3% | 120 | 0.0% | 0.00% | – |
| Q3 2014 | $3,000 | -25.0% | 120 | 0.0% | 0.00% | – |
| Q2 2014 | $4,000 | -42.9% | 120 | -55.9% | 0.00% | – |
| Q1 2014 | $7,000 | +250.0% | 272 | +126.7% | 0.00% | – |
| Q4 2013 | $2,000 | -98.5% | 120 | -95.6% | 0.00% | -100.0% |
| Q3 2013 | $130,000 | – | 2,755 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 1,010,330 | $122,472,203 | 13.56% |
| Finepoint Capital LP | 145,357 | $17,620,176 | 8.78% |
| Avoro Capital Advisors LLC | 4,025,000 | $487,910,500 | 7.61% |
| Saturn V Capital Management LP | 118,401 | $14,352,569 | 6.01% |
| Ghost Tree Capital, LLC | 150,000 | $18,183,000 | 5.98% |
| Ikarian Capital, LLC | 3,673 | $44,524,106 | 5.36% |
| ACUTA CAPITAL PARTNERS, LLC | 550 | $7,580,650 | 5.08% |
| Eagle Health Investments LP | 174,212 | $21,117,979 | 4.65% |
| Boxer Capital, LLC | 600,000 | $72,732,000 | 3.87% |
| GREAT POINT PARTNERS LLC | 165,200 | $20,025,544 | 3.65% |